These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35886046)

  • 41. High Irisin levels in nondiabetic HIV-infected males are associated with insulin resistance, nonalcoholic fatty liver disease, and subclinical atherosclerosis.
    Moreno-Perez O; Reyes-Garcia R; Muñoz-Torres M; Merino E; Boix V; Reus S; Giner L; Alfayate R; Garcia-Fontana B; Sanchez-Paya J; Picó A; Portilla J
    Clin Endocrinol (Oxf); 2018 Oct; 89(4):414-423. PubMed ID: 29947044
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease.
    Nadinskaia M; Maevskaya M; Ivashkin V; Kodzoeva K; Pirogova I; Chesnokov E; Nersesov A; Kaibullayeva J; Konysbekova A; Raissova A; Khamrabaeva F; Zueva E
    World J Gastroenterol; 2021 Mar; 27(10):959-975. PubMed ID: 33776366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sex differential genetic effect of chromosome 9p21 on subclinical atherosclerosis.
    Lin HF; Tsai PC; Lin RT; Khor GT; Sheu SH; Juo SH
    PLoS One; 2010 Nov; 5(11):e15124. PubMed ID: 21152093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessment of endothelial function in patients with nonalcoholic fatty liver disease.
    Colak Y; Senates E; Yesil A; Yilmaz Y; Ozturk O; Doganay L; Coskunpinar E; Kahraman OT; Mesci B; Ulasoglu C; Tuncer I
    Endocrine; 2013 Feb; 43(1):100-7. PubMed ID: 22661277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
    Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease.
    Yari FA; Shabani P; Karami S; Sarmadi N; Poustchi H; Bandegi AR
    BMC Endocr Disord; 2021 Aug; 21(1):153. PubMed ID: 34344333
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Correlation Between Carotid Intima Media Thickness and Non-Alcoholic Fatty Liver Disease.
    Kumari S; Porwal YC; Gupta R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443534
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of sLR11 gene polymorphism with T2DM and carotid atherosclerosis.
    Du F; Li D; Piao LS; Yang KJ
    Technol Health Care; 2018; 26(3):391-400. PubMed ID: 29865095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.
    Sato M; Kamada Y; Takeda Y; Kida S; Ohara Y; Fujii H; Akita M; Mizutani K; Yoshida Y; Yamada M; Hougaku H; Takehara T; Miyoshi E
    Liver Int; 2015 Mar; 35(3):925-35. PubMed ID: 25627311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of methylenetetrahydrofolate reductase C677T polymorphism with markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns Study.
    Collings A; Raitakari OT; Juonala M; Rontu R; Kähönen M; Hutri-Kähönen N; Rönnemaa T; Marniemi J; Viikari JS; Lehtimäki T
    Scand J Clin Lab Invest; 2008; 68(1):22-30. PubMed ID: 17934972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease.
    Ozturk K; Dogan T; Celikkanat S; Ozen A; Demirci H; Kurt O; Turker T; Yilmaz Y; Uygun A
    Eur J Gastroenterol Hepatol; 2018 Apr; 30(4):411-417. PubMed ID: 29309395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between Nonalcoholic Fatty Liver Disease and Carotid Artery Atherosclerosis Beyond Metabolic Disorders in Non-Diabetic Patients.
    Kang JH; Cho KI; Kim SM; Lee JY; Kim JJ; Goo JJ; Kim KN; Jhi JH; Kim DJ; Lee HG; Kim TI
    J Cardiovasc Ultrasound; 2012 Sep; 20(3):126-33. PubMed ID: 23185655
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease.
    Aygun C; Kocaman O; Sahin T; Uraz S; Eminler AT; Celebi A; Senturk O; Hulagu S
    Dig Dis Sci; 2008 May; 53(5):1352-7. PubMed ID: 17939039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Non-alcoholic fatty liver disease is associated with carotid artery wall thickness in diet-controlled type 2 diabetic patients.
    Targher G; Bertolini L; Padovani R; Poli F; Scala L; Zenari L; Zoppini G; Falezza G
    J Endocrinol Invest; 2006 Jan; 29(1):55-60. PubMed ID: 16553034
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of gene polymorphism in lipocalin-type prostaglandin D synthase and its association with carotid atherosclerosis in Japanese hypertensive patients.
    Miwa Y; Takiuchi S; Kamide K; Yoshii M; Horio T; Tanaka C; Banno M; Miyata T; Sasaguri T; Kawano Y
    Biochem Biophys Res Commun; 2004 Sep; 322(2):428-33. PubMed ID: 15325247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
    Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
    Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
    Wang CC; Lin SK; Tseng YF; Hsu CS; Tseng TC; Lin HH; Wang LY; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1411-6. PubMed ID: 19702910
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Apolipoprotein A-I/C-III/A-IV SstI and apolipoprotein B XbaI polymorphisms and their association with carotid artery intima-media thickness in the Finnish population. The Cardiovascular Risk in Young Finns Study.
    Islam MS; Raitakari OT; Juonala M; Kähönen M; Hutri-Kähönen N; Collings A; Aalto-Setälä K; Kontula K; Marniemi J; Viikari JS; Lehtimäki T
    Atherosclerosis; 2005 May; 180(1):79-86. PubMed ID: 15823278
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonalcoholic Fatty Liver Disease for Identification of Preclinical Carotid Atherosclerosis.
    Sinn DH; Cho SJ; Gwak GY; Cho J; Gu S; Seong D; Kang D; Kim H; Yi BK; Paik SW
    Medicine (Baltimore); 2016 Jan; 95(3):e2578. PubMed ID: 26817915
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.